Clinical Trial Update: Efficacy of the Dreem 3S Ambulatory Sleep Monitoring Device for the Evaluation of Narcolepsy

View source ↗

Summary

A completed clinical trial evaluated the efficacy of the Dreem 3S ambulatory sleep monitoring device for evaluating Narcolepsy Type 1 and hypersomnia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypersomnia
• Narcolepsy Type

Snippet

Sponsor: Beacon Biosignals | Conditions: Narcolepsy Type 1, Hypersomnia | Status: COMPLETED